Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group holds a focused book of 27 stocks worth $380.8M as of Q2 2026 (disclosed Jul 30, 2026, a ~30-day 13F lag). This quarter they opened Coeur Mining Inc and trimmed Micron Technology Inc. Their largest long position is Alphabet Inc-CL A at 11% of the equity book. Cloning the disclosed picks since 2024 would be +77% (+38.6%/yr). That is a simulation of the disclosed long book, not audited returns.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/2033881/holdings"
Use Arkolith to show Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group's latest holdings, largest changes, and filing provenance.
Following at the filing date actually beat the quarter-end book by 11.6 points over this window.
Growth of $10,000 cloning Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group's disclosed long 13F book, rebalanced on each filing date (so it reflects each quarter's actual reporting lag, ~30 days for the latest filing, with no look-ahead), total-return basis (dividends reinvested), derived from end-of-day prices. “Their reported book” values the same picks from quarter-end, before they were public. S&P 500 is SPY total return over the same window. Excludes shorts, cash, options and non-13F holdings. Not investment advice.
Top-heavy: focused book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
100% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Alphabet Inc CAP STK CL A | $40.2M | 112.5K | 10.6% | ▲+72% Added · +47K sh | |
| 2 | Micron Technology Inc COM | $35.8M | 31.0K | 9.4% | ▼−31% Reduced · −14K sh | |
| 3 | Advanced Micro Devices Inc COM | $35.3M | 60.8K | 9.3% | —Held | |
| 4 | Marvell Technology Inc COM | $34.3M | 115.0K | 9.0% | —Held | |
| 5 | Nvidia Corporation COM | $31.6M | 158.0K | 8.3% | ▲+105% Added · +81K sh | |
| 6 | Microsoft Corp COM | $28.5M | 76.5K | 7.5% | —Held | |
| 7 | Amazon Com Inc COM | $26.2M | 110.0K | 6.9% | ▲+18% Added · +17K sh | |
| 8 | Apple Inc COM | $20.8M | 72.0K | 5.5% | ▲+31% Added · +17K sh | |
| 9 | Paymentus Holdings Inc COM CL A | $17.7M | 733.5K | 4.7% | —Held | |
| 10 | Snowflake Inc COM SHS | $15.6M | 61.2K | 4.1% | ▲+57% Added · +22K sh | |
| 11 | Pan Amern Silver Corp COM | $12.8M | 286.3K | 3.4% | —Held | |
| 12 | Freeport McMoran Inc CL B | $11.2M | 178.3K | 2.9% | —Held | |
| 13 | Salesforce Inc COM | $11.1M | 71.0K | 2.9% | ▲+37% Added · +19K sh | |
| 14 | Microchip Technology Inc. COM | $9.6M | 105.0K | 2.5% | —Held | |
| 15 | Doordash Inc CL A | $9.2M | 50.1K | 2.4% | —Held | |
| 16 | Servicenow Inc COM | $8.0M | 80.5K | 2.1% | ▲+68% Added · +33K sh | |
| 17 | Msci Inc COM | $6.3M | 11.2K | 1.6% | —Held | |
| 18 | Neurocrine Biosciences Inc COM | $5.1M | 30.4K | 1.3% | —Held | |
| 19 | Deckers Outdoor Corp COM | $5.1M | 51.1K | 1.3% | ▼−57% Reduced · −67K sh | |
| 20 | Syndax Pharmaceuticals Inc COM | $4.4M | 200.0K | 1.1% | —Held | |
| 21 | ConocoPhillips COM | $4.0M | 38.0K | 1.0% | —Held | |
| 22 | Stellantis N.V SHS | $2.3M | 400.0K | 0.6% | —Held | |
| 23 | Logitech Intl S A SHS | $2.2M | 23.7K | 0.6% | ▼−37% Reduced · −14K sh | |
| 24 | Nurix Therapeutics Inc COM | $2.1M | 85.0K | 0.5% | —Held | |
| 25 | Tidewater Inc New COM | $648K | 9.7K | 0.2% | —Held | |
| 26 | Arvinas Inc COM | $478K | 57.5K | 0.1% | —Held | |
| 27 | C4 Therapeutics Inc COM STK | $397K | 85.0K | 0.1% | —Held |
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | Jul 30, 2026 | 27 | $380.8M | 13F-HR |
| Q1 2026 | Mar 31, 2026 | May 5, 2026 | 28 | $262.3M | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 5, 2026 | 26 | $205.0M | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Nov 3, 2025 | 26 | $169.3M | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Aug 1, 2025 | 88 | $159.1M | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 5, 2025 | 93 | $183.5M | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Feb 10, 2025 | 85 | $171.4M | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Nov 7, 2024 | 91 | $235.0M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.